293 related articles for article (PubMed ID: 9784590)
1. Dopamine agonist treatment ameliorates hyperglycemia, hyperlipidemia, and the elevated basal insulin release from islets of ob/ob mice.
Liang Y; Lubkin M; Sheng H; Scislowski PW; Cincotta AH
Biochim Biophys Acta; 1998 Oct; 1405(1-3):1-13. PubMed ID: 9784590
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatment with sympatholytic dopamine agonists improves aberrant beta-cell hyperplasia and GLUT2, glucokinase, and insulin immunoreactive levels in ob/ob mice.
Jetton TL; Liang Y; Cincotta AH
Metabolism; 2001 Nov; 50(11):1377-84. PubMed ID: 11699060
[TBL] [Abstract][Full Text] [Related]
3. Increased responsiveness to the hyperglycemic, hyperglucagonemic and hyperinsulinemic effects of circulating norepinephrine in ob/ob mice.
Liang Y; Cincotta AH
Int J Obes Relat Metab Disord; 2001 May; 25(5):698-704. PubMed ID: 11360153
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine/SKF38393 treatment ameliorates dyslipidemia in ob/ob mice.
Zhang Y; Scislowski PW; Prevelige R; Phaneuf S; Cincotta AH
Metabolism; 1999 Aug; 48(8):1033-40. PubMed ID: 10459570
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction in isolated islets from the ob/ob mouse: enhanced sensitivity of protein kinase C to stimulation.
Zawalich WS; Zawalich KC
Biochem Biophys Res Commun; 1996 Jun; 223(3):618-23. PubMed ID: 8687445
[TBL] [Abstract][Full Text] [Related]
6. Abnormally decreased NO and augmented CO production in islets of the leptin-deficient ob/ob mouse might contribute to explain hyperinsulinemia and islet survival in leptin-resistant type 2 obese diabetes.
Jimenez-Feltstrom J; Salehi A; Meidute Abaraviciene S; Henningsson R; Lundquist I
Regul Pept; 2011 Oct; 170(1-3):43-51. PubMed ID: 21620903
[TBL] [Abstract][Full Text] [Related]
7. Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse.
Liang Y; Jetton TL; Lubkin M; Meier AH; Cincotta AH
Cell Mol Life Sci; 1998 Jul; 54(7):703-11. PubMed ID: 9711236
[TBL] [Abstract][Full Text] [Related]
8. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction.
Kooptiwut S; Kebede M; Zraika S; Visinoni S; Aston-Mourney K; Favaloro J; Tikellis C; Thomas MC; Forbes JM; Cooper ME; Dunlop M; Proietto J; Andrikopoulos S
J Mol Endocrinol; 2005 Aug; 35(1):39-48. PubMed ID: 16087720
[TBL] [Abstract][Full Text] [Related]
9. Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse.
Lavine RL; Voyles N; Perrino PV; Recant L
Am J Physiol; 1977 Aug; 233(2):E86-90. PubMed ID: 329686
[TBL] [Abstract][Full Text] [Related]
10. Increased responsiveness of ventromedial hypothalamic neurons to norepinephrine in obese versus lean mice: relation to the metabolic syndrome.
Kraszewski KZ; Cincotta AH
Int J Mol Med; 2000 Apr; 5(4):349-55. PubMed ID: 10719049
[TBL] [Abstract][Full Text] [Related]
11. Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse.
Black M; Heick HM; Bégin-Heick N
Biochem J; 1986 Sep; 238(3):863-9. PubMed ID: 3026362
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice.
Cincotta AH; Tozzo E; Scislowski PW
Life Sci; 1997; 61(10):951-6. PubMed ID: 9296333
[TBL] [Abstract][Full Text] [Related]
13. Persistently enhanced sensitivity of pancreatic islets from ob/ob mice to PKC-stimulated insulin secretion.
Chen NG; Romsos DR
Am J Physiol; 1997 Feb; 272(2 Pt 1):E304-11. PubMed ID: 9124339
[TBL] [Abstract][Full Text] [Related]
14. Different insulin-secretory responses to calcium-channel blockers in islets of lean and obese (ob/ob) mice.
Black MA; Fournier LA; Heick HM; Bégin-Heick N
Biochem J; 1988 Jan; 249(2):401-7. PubMed ID: 2449178
[TBL] [Abstract][Full Text] [Related]
15. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists.
Scislowski PW; Tozzo E; Zhang Y; Phaneuf S; Prevelige R; Cincotta AH
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):425-31. PubMed ID: 10340822
[TBL] [Abstract][Full Text] [Related]
16. Biochemical mechanisms involved in monomethyl succinate-induced insulin secretion.
Zawalich WS; Zawalich KC
Endocrinology; 1992 Aug; 131(2):649-54. PubMed ID: 1322278
[TBL] [Abstract][Full Text] [Related]
17. Threshold for glucose-stimulated insulin secretion in pancreatic islets of genetically obese (ob/ob) mice is abnormally low.
Chen NG; Tassava TM; Romsos DR
J Nutr; 1993 Sep; 123(9):1567-74. PubMed ID: 8360782
[TBL] [Abstract][Full Text] [Related]
18. Insulin secretion from ob/ob mouse pancreatic islets: effects of neurotransmitters.
Tassava TM; Okuda T; Romsos DR
Am J Physiol; 1992 Mar; 262(3 Pt 1):E338-43. PubMed ID: 1550226
[TBL] [Abstract][Full Text] [Related]
19. Modulation of islet G-proteins, alpha-glucosidehydrolase inhibition and insulin release stimulated by various secretagogues.
Salehi A; Lundquist I
Biosci Rep; 1996 Feb; 16(1):23-34. PubMed ID: 8861537
[TBL] [Abstract][Full Text] [Related]
20. Effects of cholinergic m-receptor agonists on insulin release in islets from obese and lean mice of different ages: the importance of bicarbonate.
Persson-Sjögren S; Lindström P
Pancreas; 2004 Nov; 29(4):e90-9. PubMed ID: 15502638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
